Eledon Pharmaceuticals, Inc. ( ELDN) - Stock Earnings
ELDN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -17.5 million USD | — USD |
| 2025Q4 | -10.4 million USD | — USD |
| 2026Q1 | -39.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ELDN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.3 million USD | — USD |
| 2024 | -36.2 million USD | — USD |
| 2025 | -45.6 million USD | — USD |
| 2026 Est. | — | — |
ELDN
Price: $3.48
52 week price:
Earnings Per Share: -0.77 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 24400
Market Capitalization: 215.8 million